Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$26.68 -0.71 (-2.59%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Construction in Progress (2013 - 2015)

Updated

Amphastar Pharmaceuticals' Construction in Progress was $29.5 million in Q2 2015, up 49.0% from $19.8 million a year earlier and up 3.5% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Construction in Progress (2013 - 2015) Analysis & Trends

At the end of FY2014, Construction in Progress at Amphastar Pharmaceuticals came in at $25.07 million, up 59.8% from FY2013.

  • In earlier years, Construction in Progress was $15.69 million in FY2013.
  • Per Business Quant data, AMPH's Construction in Progress in the three quarters before Q2 2015 was $28.52 million (Q1 2015), $25.07 million (Q4 2014) and $20.32 million (Q3 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Amphastar Pharmaceuticals 1.16 Bn 23.86 Mn 93.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 29.50 Mn
Mar 31, 2015 28.52 Mn
Dec 31, 2014 25.07 Mn
Sep 30, 2014 20.32 Mn
Jun 30, 2014 19.80 Mn
Dec 31, 2013 15.69 Mn
API Access

Amphastar Pharmaceuticals Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=AMPH&period=max&api_key=YOUR_API_KEY